Rhythm Pharmaceuticals Inc. (referred to as Rhythm Pharmaceuticals) recently disclosed that some of its shareholders plan to further sell up to 2.4 million shares of common stock.
Show original
This stock sale plan is led by existing shareholders, aiming to achieve their personal asset allocation goals. The transaction is expected to provide additional liquidity to the market, while potentially having some impact on the existing equity structure. The company emphasizes that this stock sale is a personal financial arrangement by the shareholders and does not involve the issuance of new shares by Rhythm Pharmaceuticals, so it will not have a dilutive effect on the company's total capital.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
0G Labs and the Stanford Blockchain team launch the $20 million Apollo AI Accelerator
Odaily星球日报•2026/02/27 01:44
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$67,201.69
-1.67%
Ethereum
ETH
$2,013.57
-2.06%
Tether USDt
USDT
$1
-0.01%
XRP
XRP
$1.4
-1.74%
BNB
BNB
$625.42
-0.50%
USDC
USDC
$1
-0.01%
Solana
SOL
$85.85
-3.01%
TRON
TRX
$0.2853
-0.22%
Dogecoin
DOGE
$0.09694
-3.85%
Cardano
ADA
$0.2872
-3.29%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now